Revelation Biosciences Warrant
REVBW
9 hedge funds and large institutions have $10.5K invested in Revelation Biosciences Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
56% more capital invested
Capital invested by funds: $6.76K → $10.5K (+$3.78K)
10.22% less ownership
Funds ownership: 22.02% → 11.8% (-10%)
18% less funds holding
Funds holding: 11 → 9 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
+$2.25K |
| 2 |
HF
HRT Financial
New York
|
+$202 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$654 |
| 2 |
TSS
Two Sigma Securities
New York
|
-$72 |
| 3 |
Walleye Capital
New York
|
-$71 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$34 |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$26 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $3.7K | – | – | – |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $2.68K | – | – | – |
|
|
PVI
3
Pine Valley Investments
Marlton,
New Jersey
| $2.65K | +$2.25K | +146,139 | +147% |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $591 | – | – | – |
|
5
Jane Street
New York
| $540 | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $366 | -$26 | -1,667 | -4% |
|
|
PIS
7
POM Investment Strategies
Raleigh,
North Carolina
| $11 | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $3 | -$34 | -2,240 | -89% |
|
|
9
Walleye Trading
New York
| – | -$654 | -93,435 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$72 | -10,354 | Closed |
|
|
11
Walleye Capital
New York
| – | -$71 | -10,074 | Closed |
|
|
HF
12
HRT Financial
New York
| – | +$202 | +13,144 | New |
|
REVBW Hedge Fund Activity: Q1 2025 in Review
9 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2025, worth a combined $10.5K — up 56% from $6.76K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of REVBW and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Pine Valley Investments, adding an estimated $2.25K. The largest seller was Walleye Trading, exiting entirely with an estimated $654 sold.
- 9 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2025, down from 11 in Q4 2024.
- Funds reported $10.5K of Revelation Biosciences Warrant stock for Q1 2025, up 56% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q1 2025 and 3 closed out, a net change of -2 holders.
- The largest Revelation Biosciences Warrant buyer in Q1 2025 was Pine Valley Investments, an estimated $2.25K added.
- The largest Revelation Biosciences Warrant seller in Q1 2025 was Walleye Trading, an estimated $654 sold.
Based on aggregated 13F filings for Q1 2025.